Skip Navigation

Cardiovascular Research 2001 51(1):21-29; doi:10.1016/S0008-6363(01)00313-3
© 2001 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lango, R
Right arrow Articles by Lysiak-Szydlowska, W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lango, R
Right arrow Articles by Lysiak-Szydlowska, W
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2000, European Society of Cardiology

Influence of L-carnitine and its derivatives on myocardial metabolism and function in ischemic heart disease and during cardiopulmonary bypass

R Langoa,*, R.T Smolenskib, M Narkiewiczc, J Suchorzewskaa and W Lysiak-Szydlowskad

aChair and Department of Anesthesiology and Intensive Care, Medical University of Gdansk, Debinki 80-211 Gdansk, Poland
bDepartment of Biochemistry, Medical University of Gdansk, Gdansk, Poland
cClinic of Cardiac Surgery Medical University of Gdansk, Gdansk, Poland
dDepartment of Clinical Nutrition, Medical University of Gdansk, Gdansk, Poland

* Corresponding author. Tel.: +48-58-349-2482; fax: +48-58-349-4858 rlango{at}amg.gda.pl

Carnitine and its derivatives have recently been shown to protect cardiac metabolism and function in ischemic heart disease and other clinical conditions of myocardial ischemia. Potential mechanisms of this effect include an increase in glucose metabolism, a reduction of toxic effects of long-chain acyl-CoA and acyl-carnitine in myocytes, an increase in coronary blood flow and anti-arrhythmic effect. It has also been shown that propionyl-L-carnitine which penetrates faster than carnitine into myocytes is effective in inhibiting production of free radicals. Beneficial effects of carnitine supplementation have been demonstrated under a variety of clinical conditions such as acute cardiac ischemia, during extracorporeal circulation, in carnitine-dependent cardiomyopathy as well as in patients with chronic circulatory failure and in cardiogenic shock. However, further studies are required before carnitine administration could be recommended as a routine procedure in ischemic heart disease or before cardiopulmonary bypass.

KEYWORDS Coronary disease; Energy metabolism; Heart failure; Ischemia; Myocytes; Ventricular function


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.